Assignee
SEATTLE GENETICS INC
US·87 granted patents·72 pending applications·6,062 citations·filing 1999–2020
Top patents by PatentIndex Score
159 records- 0199US10808039B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2019·Granted Oct 20, 2020·18 cites·10 claims
- 0299US8039273B2β-glucuronide-linker drug conjugatesSEATTLE GENETICS INC·Filed 2006·Granted Oct 18, 2011·94 cites·27 claims
- 0399US7994135B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Aug 9, 2011·164 cites·51 claims
- 0499US7989434B2Heterocyclic self-immolative linkers and conjugatesSEATTLE GENETICS INC·Filed 2010·Granted Aug 2, 2011·127 cites·19 claims
- 0599US7964566B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·209 cites·60 claims
- 0699US7964567B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·134 cites·42 claims
- 0799US7851437B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Dec 14, 2010·163 cites·42 claims
- 0899US7829531B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Nov 9, 2010·199 cites·81 claims
- 0999US7754681B2Heterocyclic self-immolative linkers and conjugatesSEATTLE GENETICS INC·Filed 2007·Granted Jul 13, 2010·229 cites·19 claims
- 1099US7745394B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 29, 2010·193 cites·44 claims
- 1199US7659241B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2003·Granted Feb 9, 2010·442 cites·78 claims
- 1299US7553816B2p-amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2002·Granted Jun 30, 2009·178 cites·51 claims
- 1399US7498298B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·1.1k cites·22 claims
- 1499US7375078B2Heterocyclic self-immolative linkers and conjugatesSEATTLE GENETICS INC·Filed 2005·Granted May 20, 2008·326 cites·3 claims
- 1599US7091186B2p-Amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2001·Granted Aug 15, 2006·211 cites·38 claims
- 1699US6884869B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2001·Granted Apr 26, 2005·562 cites·2 claims
- 1798US9713647B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 25, 2017·26 cites·10 claims
- 1898US7968687B2CD19 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2008·Granted Jun 28, 2011·139 cites·14 claims
- 1998US7750116B1Antibody drug conjugate metabolitesSEATTLE GENETICS INC·Filed 2007·Granted Jul 6, 2010·199 cites·1 claims
- 2098US7098308B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2004·Granted Aug 29, 2006·101 cites·6 claims
- 2197US9701752B2Humanized anti-CD70 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2016·Granted Jul 11, 2017·30 cites·25 claims
- 2297US8343928B2Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminusSEATTLE GENETICS INC·Filed 2006·Granted Jan 1, 2013·55 cites·26 claims
- 2397US7837980B2Partially loaded antibodies and methods of their conjugationSEATTLE GENETICS INC·Filed 2005·Granted Nov 23, 2010·98 cites·26 claims
- 2497US7491390B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2005·Granted Feb 17, 2009·60 cites·28 claims
- 2597US7423116B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2006·Granted Sep 9, 2008·51 cites·24 claims
- 2697US7090843B1Recombinant anti-CD30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2000·Granted Aug 15, 2006·155 cites·18 claims
- 2796US10722549B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Jul 28, 2020·7 cites·23 claims
- 2896US9592240B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Mar 14, 2017·23 cites·11 claims
- 2996US9526798B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Dec 27, 2016·21 cites·4 claims
- 3096US7666422B2Methods for the treatment of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Feb 23, 2010·30 cites·17 claims
- 3196US7256257B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2002·Granted Aug 14, 2007·69 cites·52 claims
- 3295US10414826B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2017·Granted Sep 17, 2019·8 cites·20 claims
- 3395US9919061B2CD19 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2015·Granted Mar 20, 2018·9 cites·16 claims
- 3495US9707301B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 18, 2017·21 cites·10 claims
- 3595US9504756B2Self-stabilizing linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Nov 29, 2016·26 cites·15 claims
- 3695US9428585B2Humanized anti-CD70 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2013·Granted Aug 30, 2016·26 cites·31 claims
- 3795US7641903B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2007·Granted Jan 5, 2010·45 cites·22 claims
- 3895US6843989B1Methods for the treatment and prevention of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2000·Granted Jan 18, 2005·57 cites·78 claims
- 3995US6838261B1Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteinsSEATTLE GENETICS INC·Filed 2000·Granted Jan 4, 2005·61 cites·35 claims
- 4094US10098963B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2017·Granted Oct 16, 2018·10 cites·8 claims
- 4194US9713648B2Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2015·Granted Jul 25, 2017·11 cites·4 claims
- 4294US9387259B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Jul 12, 2016·24 cites·22 claims
- 4394US7824683B2Methods for augmenting an immune response using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Nov 2, 2010·18 cites·14 claims
- 4494US7695716B2Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2008·Granted Apr 13, 2010·75 cites·38 claims
- 4593US9816069B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2015·Granted Nov 14, 2017·6 cites·20 claims
- 4693US9463252B2Auristatin drug linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Oct 11, 2016·13 cites·43 claims
- 4793US8993326B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2013·Granted Mar 31, 2015·9 cites·20 claims
- 4893US6946129B1Recombinant anti-CD40 antibody and uses thereofSEATTLE GENETICS INC·Filed 1999·Granted Sep 20, 2005·70 cites·21 claims
- 4992US10478469B2Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Nov 19, 2019·6 cites·30 claims
- 5092US8992932B2Binder-drug conjugates (ADCs) and use thereofSEATTLE GENETICS INC·Filed 2012·Granted Mar 31, 2015·26 cites·12 claims
Showing the top 50 of 159 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →